AI in Healthcare May 22, 2020
Researchers have demonstrated a way to visually explore small-molecule inhibitors that, according to algorithmic suggestions, show potential for targeting COVID-19’s main proteins.
The team, comprised of investigators at the San Diego virtual-reality startup Nanome and an AI drug-discovery company based in Hong Kong, Insilico Medicine, describe their work in ResearchGate and chemrxiv.org.
Nanome has additionally sent an announcement describing the collaboration’s technical advancement in lay language.
“Many potential therapeutics aimed at containing the spread of SARS-CoV-2 have targeted the S, or spike, protein, a surface protein that plays a vital role...